SERPINC1: A Potential Drug Target and Biomarker for Serine Proteinase Inhibition

Target Name: SERPINC1

NCBI ID: G462

SERPINC1

SERPINC1: A Potential Drug Target and Biomarker for Serine Proteinase Inhibition

Serine proteinase (serine proteasome) is a family of enzymes that play a crucial role in cellular signaling and homeostasis. These enzymes are involved in the regulation of various cellular processes, including cell signaling, DNA replication, and protein synthesis. Serine proteinase is also involved in the regulation of inflammation and immune responses. Therefore, serine proteinase has been identified as a potential drug target in the field of pharmacology.

SERPINC1 is a protein that belongs to the serine proteinase inhibitor subfamily C. It is a member of the clade C and has been identified as a potential drug target and biomarker. SERPINC1 is a 12-kDa protein that is expressed in various tissues and cells in the body. It is highly conserved and has a distinct subcellular localization in the cytoplasm of the cells.

The SERPINC1 gene has four exons, which encode the four distinct subunits of SERPINC1. These subunits are involved in the regulation of various cellular processes and have distinct functions. The first subunit, SERPIN1, is involved in the regulation of cell signaling, while the second subunit, SERPIN2, is involved in the regulation of DNA replication and repair. The third subunit, SERPIN3, is involved in the regulation of protein synthesis, while the fourth subunit, SERPIN4, is involved in the regulation of inflammation and immune responses.

SERPINC1 has been shown to be involved in the regulation of cellular processes that are important for the maintenance of cellular homeostasis. For example, SERPINC1 has been shown to be involved in the regulation of cell signaling, which is critical for the regulation of cellular processes that are essential for the maintenance of cellular homeostasis. In addition, SERPINC1 has also been shown to be involved in the regulation of DNA replication and repair, which is critical for the regulation of cell growth and development.

SERPINC1 has also been shown to be involved in the regulation of protein synthesis, which is critical for the regulation of cellular processes that are essential for the maintenance of cellular homeostasis. In addition, SERPINC1 has also been shown to be involved in the regulation of inflammation and immune responses, which is critical for the regulation of cellular processes that are essential for the maintenance of cellular homeostasis.

In conclusion, SERPINC1 is a protein that is involved in the regulation of various cellular processes that are essential for the maintenance of cellular homeostasis. Therefore, it is a potential drug target and biomarker that can be targeted by small molecules or antibodies to inhibit its function. Further research is needed to fully understand the function of SERPINC1 and its potential as a drug target and biomarker.

Protein Name: Serpin Family C Member 1

Functions: Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade (PubMed:15853774, PubMed:15140129). AT-III inhibits thrombin, matriptase-3/TMPRSS7, as well as factors IXa, Xa and XIa (PubMed:15140129). Its inhibitory activity is greatly enhanced in the presence of heparin

The "SERPINC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SERPINC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets